India to Reward Whistleblowers for Helping Nab Spurious Drugs

International Pharmaceutical Regulatory Monitor
A A
In an effort to dispel a perception that Indian drugs are poorly made, the government is offering whistleblowers a hefty reward for providing information on spurious, adulterated and misbranded products.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00